Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...
Syntax Systems, a global technology solutions and services provider for cloud application implementation and management, has officially acquired Montreal-based Beyond Technologies, enabling the ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
Syntax Bio, a privately held synthetic biology company focused on cell therapies, on Sunday said it expanded its Series A financing round to $14.4 million, bringing total funding raised to more than ...
NEW YORK--(BUSINESS WIRE)--Syntax (www.syntaxindices.com), a provider of innovative financial data and technologies, announced that Patrick Shaddow has assumed the role of CEO, effective January 1, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results